Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MSA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02705755
What this trial is testing

TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)

Who this might be right for
Neurogenic Orthostatic HypotensionMultiple System Atrophy (MSA) With Orthostatic HypotensionPure Autonomic Failure+5 more
Theravance Biopharma 34
Testing effectiveness (Phase 2)Study completedNCT03033680
What this trial is testing

Establishing 18F-PBR06 PET Imaging as a Viable Pharmacodynamic Endpoint in MSA

Who this might be right for
MSA
Brigham and Women's Hospital 17
Very early researchLooking for participantsNCT07617688
What this trial is testing

Evaluation of the Pharmacokinetics, Biodistribution and Radiation Dosimetry of [18F]MODAG-009 Positron Emission Tomography (PET) Radiotracers in Adult Healthy Volunteers

Who this might be right for
Healthy Adult
MODAG GmbH 6
Very early researchUnknownNCT05039905
What this trial is testing

SLN Detection With Tc-MSA-ICG in Lung Cancer Patients

Who this might be right for
Lung Cancer
Korea University Guro Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT06568237
What this trial is testing

A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy

Who this might be right for
Multiple System Atrophy
Teva Branded Pharmaceutical Products R&D LLC 350
Early research (Phase 1)Study completedNCT00439361
What this trial is testing

Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaLymphoma
M.D. Anderson Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT01329900
What this trial is testing

Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 50
Early research (Phase 1)Study completedNCT02270489
What this trial is testing

Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA

Who this might be right for
Multiple System AtrophyNeurodegenerative Diseases
Affiris AG 30
Not applicableStudy completedNCT02730078
What this trial is testing

Value-based Emotion-focused Educational Programme to Reduce Diabetes-related Distress

Who this might be right for
Type 2 Diabetes Mellitus
Universiti Putra Malaysia 124
Testing effectiveness (Phase 2)Study completedNCT01010217
What this trial is testing

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

Who this might be right for
Blood Stem Cell Transplant FailureLeukemiaHematologic Malignancies
M.D. Anderson Cancer Center 176
Early research (Phase 1)Ended earlyNCT00040651
What this trial is testing

Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients

Who this might be right for
SclerodermaSystemic Sclerosis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 15
Not applicableActive Not RecruitingNCT05453058
What this trial is testing

Observational Study in Multiple System Atrophy

Who this might be right for
Multiple System Atrophy
H. Lundbeck A/S 90
Early research (Phase 1)Looking for participantsNCT07289477
What this trial is testing

A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy

Who this might be right for
Multiple System Atrophy - Parkinsonian Subtype (MSA-P)
iRegene Therapeutics Co., Ltd. 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT06001385
What this trial is testing

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemia+8 more
Center for International Blood and Marrow Transplant Research 313
Not applicableLooking for participantsNCT07324330
What this trial is testing

Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity

Who this might be right for
Parkinson DiseaseProdromal StageNeurodegenerative Diseases+7 more
University Hospital, Bonn 130
Testing effectiveness (Phase 2)Study completedNCT03753763
What this trial is testing

Safinamide for Multiple System Atrophy (MSA)

Who this might be right for
Multiple System Atrophy
Zambon SpA 49
Testing effectiveness (Phase 2)Looking for participantsNCT06868628
What this trial is testing

A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)

Who this might be right for
Multiple System Atrophy
Tiziana Life Sciences LTD 5
Not applicableUnknownNCT02778607
What this trial is testing

PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK

Who this might be right for
Progressive Supranuclear Palsy (PSP)Corticobasal DegenerationMultiple System Atrophy (MSA)
University College, London 900
Not applicableEnded earlyNCT00758667
What this trial is testing

Chemically Assisted Capsulectomy-A New Clinical Approach

Who this might be right for
Implant Capsular Contracture
Vanderbilt University 20
Not applicableStudy completedNCT05807373
What this trial is testing

Differential Diagnosis Between Parkinson's Disease and Multiple System Atrophy Using Digital Speech Analysis - Part 2

Who this might be right for
Parkinson DiseaseMultiple System Atrophy
University Hospital, Bordeaux 28
Next Page